FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,944,000 | -13.1% | 51,600 | -60.8% | 0.04% | -23.4% |
Q4 2020 | $2,237,000 | +262.0% | 131,500 | 0.0% | 0.05% | +235.7% |
Q3 2020 | $618,000 | -39.2% | 131,500 | -21.0% | 0.01% | -33.3% |
Q2 2020 | $1,016,000 | +268.1% | 166,500 | +37.0% | 0.02% | +250.0% |
Q1 2020 | $276,000 | -58.9% | 121,500 | -17.1% | 0.01% | -33.3% |
Q4 2019 | $672,000 | +246.4% | 146,500 | +193.0% | 0.01% | +200.0% |
Q3 2019 | $194,000 | -39.0% | 50,000 | +468.2% | 0.00% | -25.0% |
Q1 2017 | $318,000 | +52.9% | 8,800 | +76.0% | 0.00% | 0.0% |
Q4 2015 | $208,000 | -66.2% | 5,000 | -87.5% | 0.00% | -69.2% |
Q3 2015 | $616,000 | -38.0% | 40,000 | 0.0% | 0.01% | -35.0% |
Q2 2015 | $994,000 | +8.8% | 40,000 | 0.0% | 0.02% | +5.3% |
Q1 2015 | $914,000 | -50.9% | 40,000 | -42.0% | 0.02% | -54.8% |
Q4 2014 | $1,863,000 | +169.2% | 69,000 | +16.9% | 0.04% | +147.1% |
Q3 2014 | $692,000 | +85.5% | 59,000 | +145.8% | 0.02% | +70.0% |
Q2 2014 | $373,000 | -21.0% | 24,000 | 0.0% | 0.01% | -28.6% |
Q1 2014 | $472,000 | – | 24,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,381,117 | $47,065,000 | 4.14% |
GREAT POINT PARTNERS LLC | 1,647,753 | $22,937,000 | 3.58% |
Rock Springs Capital Management LP | 598,000 | $8,324,000 | 0.30% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 136,029 | $1,894,000 | 0.14% |
FOX RUN MANAGEMENT, L.L.C. | 20,935 | $291,000 | 0.13% |
Hilltop Holdings Inc. | 39,824 | $554,000 | 0.12% |
WEXFORD CAPITAL LP | 112,700 | $1,569,000 | 0.10% |
OXFORD ASSET MANAGEMENT LLP | 296,339 | $4,132,000 | 0.09% |
Vident Investment Advisory, LLC | 133,272 | $1,855,000 | 0.07% |
ALTRINSIC GLOBAL ADVISORS LLC | 90,000 | $1,253,000 | 0.06% |